Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FXOther monoclonal antibodies and antibody drug conjugates
- Chemical substanceL01FX32Elranatamab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 2 registrations
Singapore
HSA · 2 registrations
United States
FDA · 2 registrations
At a glance
- ATC code
- L01FX32
- Registers
- 8
- Registrations
- 11
- With their own page
- 11
- Companies
- 5
All medicines with Elranatamab
Human medicines from every register that match Elranatamab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
11 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Elrexfio | United States | 12MG | solution | Marketed | Pfizer INC |
| Elrexfio | United States | 44MG/1.1ML | Injection | Marketed | Pfizer Inc. |
| Elrexfio | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Elrexfio | Canada | 76 MG / 1.9 ML | Solution | Marketed | Pfizer Canada Ulc |
| Elrexfio | Canada | 44 MG / 1.1 ML | Solution | Marketed | Pfizer Canada Ulc |
| Elrexfio 40 MG/ML Solucion Inyectable | Spain | 40 mg | solución inyectable | Marketed | Pfizer Europe Ma Eeig |
| Elrexfio | Brazil | Authorised | Pfizer Brasil Ltda | ||
| ELREXFIO 40 mg/ml oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Pfizer Europe MA EEIG | |
| Elrexfio | Croatia | Marketed | |||
| Elrexfio Solution for Injection 44 MG/1.1 ML | Singapore | 44 mg/1.1 ml | injection, solution | Authorised | Pfizer Private Limited |
| Elrexfio Solution for Injection 76 MG/1.9 ML | Singapore | 76 mg/1.9 ml | injection, solution | Authorised | Pfizer Private Limited |